Tag: Nice
-

Outdated NHS Guidelines Leave Cancer Patients Facing a Death Sentence, Says Ex-Minister
UK Cancer Care Under Scrutiny as Second Transplants Denied Cancer patients facing a second stem cell transplant are being refused under current NHS guidelines, a decision condemned by former Conservative minister Sir Gavin Williamson as a potential death sentence. The debate centers on whether the National Institute for Health and Care Excellence (NICE) criteria and…
-

NICE Recommends AUCATZYL (obecabtagene autoleucel) for UK patients
Summary: NICE backs AUCATZYL for eligible patients The National Institute for Health and Care Excellence (NICE) has recommended AUCATZYL, the CAR-T cell therapy obatabtagene autoleucel (also known as obecabtagene autoleucel), for use within the UK’s healthcare system. The decision marks a significant milestone for patients with certain hematologic cancers and highlights the growing role of…
-

NICE Recommends AUCATZYL® (obecabtagene autoleucel) for Wider Patient Access in the UK
Overview: NICE Endorses AUCATZYL for Expanded Use The National Institute for Health and Care Excellence (NICE) has recommended AUCATZYL® (obecabtagene autoleucel) for a broader patient population in the United Kingdom. This decision follows a rigorous review of clinical data, cost-effectiveness, and real-world impact on NHS services. AUCATZYL is a next-generation CAR-T therapy designed to harness…
-

NICE Recommends AUCATZYL for CAR-T Therapy: What It Means for Patients
Introduction: A pivotal NICE Recommendation The National Institute for Health and Care Excellence (NICE) has endorsed AUCATZYL (obecabtagene autoleucel) for use in eligible patients, signaling a major milestone for CAR-T cell therapy in the healthcare system. This endorsement places AUCATZYL among the select therapies that have gained formal approval for coverage and reimbursement, potentially expanding…
-

England and Wales Set to Welcome HIV-Prevention Jab CAB-LA as Game-Changing PrEP Option
Overview: A new chapter in HIV prevention A potential breakthrough in the fight against HIV is on the cusp of becoming standard care in England and Wales. Cabotegravir, known as CAB-LA, is an injectable pre-exposure prophylaxis (PrEP) option that could be administered every two months to reduce the risk of HIV infection among HIV-negative adults…
-

England and Wales poised to approve game-changing HIV prevention jab
New injectable PrEP set to reshape HIV prevention England and Wales are nearing a landmark decision that could alter the landscape of HIV prevention. A long-acting injectable drug, cabotegravir (CAB-LA), is recommended for use in adults and young people who are HIV-negative, with the aim of reducing new infections. Unlike the routine daily tablets used…
-

Nice vs Paris FC: Paris FC Fight Back After Going Behind
Match recap: a tense night at the Allianz Riviera Nice and Paris FC delivered a lively Ligue 1 encounter in the south of France, with the Aiglons dictating possession but the visitors showing resilience. The opening goal came just before the break when a clever sequence culminated in Diop firing home after a decisive pass…
-

Live: Nice vs Paris FC – Paris FC push for comeback after deficit
Live updates from Allianz Riviera: Nice vs Paris FC Nice started this Ligue 1 clash with intent, and their pressure paid off just before half-time. A well-worked sequence culminated in Diop finishing through the legs of Nkambadio after a clever pass from Cho, giving the home side a 1-0 lead at the break. The first…


